Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Equity Bancshares (EQBK) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Equity Bancshares (EQBK) over the last 10 years, with Q3 2025 value amounting to $699.4 million.

  • Equity Bancshares' Cash & Equivalents rose 19701.08% to $699.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $699.4 million, marking a year-over-year increase of 19701.08%. This contributed to the annual value of $383.7 million for FY2024, which is 122.61% up from last year.
  • Equity Bancshares' Cash & Equivalents amounted to $699.4 million in Q3 2025, which was up 19701.08% from $366.2 million recorded in Q2 2025.
  • In the past 5 years, Equity Bancshares' Cash & Equivalents ranged from a high of $699.4 million in Q3 2025 and a low of $90.0 million during Q1 2022
  • In the last 5 years, Equity Bancshares' Cash & Equivalents had a median value of $235.5 million in 2024 and averaged $255.3 million.
  • As far as peak fluctuations go, Equity Bancshares' Cash & Equivalents crashed by 5982.83% in 2022, and later skyrocketed by 26302.43% in 2023.
  • Equity Bancshares' Cash & Equivalents (Quarter) stood at $260.0 million in 2021, then plummeted by 59.83% to $104.4 million in 2022, then skyrocketed by 263.02% to $379.1 million in 2023, then rose by 1.23% to $383.7 million in 2024, then surged by 82.26% to $699.4 million in 2025.
  • Its Cash & Equivalents was $699.4 million in Q3 2025, compared to $366.2 million in Q2 2025 and $431.4 million in Q1 2025.